大動脈弁狭窄症市場：弁タイプ、手術タイプ、エンドユーザー別-2025-2030年の世界予測

大動脈弁狭窄症市場は、2023年に82億3,000万米ドルと評価され、2024年には89億9,000万米ドルに達すると予測され、CAGR 9.63％で成長し、2030年には156億7,000万米ドルになると予測されています。

大動脈弁狭窄症（AS）は、大動脈弁の開口部が狭くなり、心臓から全身への血流が制限されることを特徴とする心血管系の疾患です。大動脈弁狭窄症市場は主に高齢化によって牽引されており、高齢者はこの疾患に罹患しやすいため、診断および治療ソリューションの進歩が必要とされています。市場ソリューションの用途は、経カテーテル的大動脈弁置換術（TAVR）や外科的手技を含む複数の分野にまたがり、最終用途には専門病院や心臓治療センターなどが含まれます。主な成長要因としては、医療機器の技術的進歩、認知度と診断率の向上、熟練したヘルスケア専門家の増加などが挙げられます。最近の規制当局の承認動向や進行中の臨床試験も大きな潜在機会を示しており、低侵襲治療法の開発や患者モニタリングシステムの改善といった主要分野にスポットが当てられています。企業は、研究開発への投資やヘルスケアプロバイダーやテクノロジー企業との提携により、これらを活用することができます。しかし、市場は、治療オプションの高額なコスト、厳しい規制要件、新興国地域でのアクセス制限などの制約に直面しています。耐久性と性能を向上させた次世代バルブシステムや、患者の追跡と治療の最適化を支援するデジタルヘルスソリューションの開発において、技術革新が熟しています。バルブの材料に関する生体工学の調査や、より良い診断のための画像技術の改良は、大きな事業成長の道を提供する可能性があります。市場競争は激しく、大手企業は市場シェアを維持するためにM&Aやポートフォリオの多様化に注力しています。地理的拡大や新興市場開拓のための戦略的提携も効果的です。進化するヘルスケア規制への継続的な適応と価格感度への対応は、市場での存在感と成長の持続性をさらに高めることができます。

市場力学：急速に進化する大動脈弁狭窄症市場の主要市場インサイトを公開

大動脈弁狭窄症市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ヘルスケア・インフラとアクセシビリティを改善するための政府および民間セクターの取り組み
  • 革新的な治療法や機器の研究開発への投資拡大
  • 大動脈弁狭窄症治療に対する有利な償還政策と保険適用
  • 医療費の増加、外科手術に対する患者の意欲の高まり
• 市場抑制要因
  • 治療費の高騰
• 市場機会
  • 低侵襲治療の出現と大動脈弁狭窄症市場への潜在的影響
  • 大動脈弁狭窄症の診断精度と治療成果の向上における人工知能の役割
  • 大動脈弁狭窄症セグメントにおけるケアとコンプライアンスを強化する革新的な患者エンゲージメント戦略
• 市場の課題
  • 厳しい規制当局の承認

ポーターの5つの力：大動脈弁狭窄症市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：大動脈弁狭窄症市場における外部からの影響の把握

外部マクロ環境要因は、大動脈弁狭窄症市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析大動脈弁狭窄症市場における競合情勢の把握

大動脈弁狭窄症市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス大動脈弁狭窄症市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、大動脈弁狭窄症市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨大動脈弁狭窄症市場における成功への道筋を描く

大動脈弁狭窄症市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ヘルスケアインフラとアクセス性の向上に向けた政府と民間セクターの取り組み
    • 革新的な治療法や機器の研究開発への投資の増加
    • 大動脈弁狭窄症治療に対する有利な償還ポリシーと保険適用
    • ヘルスケア費の増加と外科的介入を受ける患者の意欲
  • 抑制要因
    • 治療費が高い
  • 機会
    • 新たな低侵襲治療とその潜在的影響大動脈弁狭窄症市場
    • 大動脈弁狭窄症の診断精度と治療成果の向上における人工知能の役割
    • 大動脈弁狭窄症セグメントにおけるケアとコンプライアンスを強化する革新的な患者エンゲージメント戦略
  • 課題
    • 厳格な規制承認
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 大動脈弁狭窄症市場バルブタイプ別

• 機械弁
• 組織弁

第7章 大動脈弁狭窄症市場手術の種類別

• 低侵襲手術
  • ロボット支援手術
  • 胸腔鏡手術
• 開胸手術
  • 胸骨全切開術
  • 部分胸骨切開術

第8章 大動脈弁狭窄症市場：エンドユーザー別

• 外来手術センター
• 心臓センター
• 病院
• 専門クリニック

第9章 南北アメリカの大動脈弁狭窄症市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の大動脈弁狭窄症市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの大動脈弁狭窄症市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Abbott Laboratories
• 2. Balton Sp. z o.o.
• 3. Biomerics
• 4. Boston Scientific
• 5. Bracco Diagnostics
• 6. Braile Biomedica
• 7. Cardiovalve
• 8. Claret Medical
• 9. CryoLife
• 10. Edwards Lifesciences
• 11. JenaValve Technology
• 12. Johnson & Johnson
• 13. LivaNova
• 14. Medtronic
• 15. Meril Life Sciences
• 16. Micro Interventional Devices
• 17. Peijia Medical
• 18. Tarilian Laser Technologies
• 19. Terumo
• 20. Transseptal Solutions

LIST OF FIGURES

• FIGURE 1. AORTIC STENOSIS MARKET RESEARCH PROCESS
• FIGURE 2. AORTIC STENOSIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL AORTIC STENOSIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL AORTIC STENOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. AORTIC STENOSIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. AORTIC STENOSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. AORTIC STENOSIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL AORTIC STENOSIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AORTIC STENOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. AORTIC STENOSIS MARKET DYNAMICS
• TABLE 7. GLOBAL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL AORTIC STENOSIS MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL AORTIC STENOSIS MARKET SIZE, BY TISSUE VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL AORTIC STENOSIS MARKET SIZE, BY ROBOT-ASSISTED SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL AORTIC STENOSIS MARKET SIZE, BY THORACOSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL AORTIC STENOSIS MARKET SIZE, BY FULL STERNOTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL AORTIC STENOSIS MARKET SIZE, BY PARTIAL STERNOTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL AORTIC STENOSIS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL AORTIC STENOSIS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL AORTIC STENOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL AORTIC STENOSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. CANADA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 43. CANADA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 44. CANADA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES AORTIC STENOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. CHINA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. CHINA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 70. CHINA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 71. CHINA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. INDIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. INDIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. INDIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 75. INDIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 76. INDIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. THAILAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. FINLAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. FRANCE AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. GERMANY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. ISRAEL AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. ITALY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ITALY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ITALY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 161. ITALY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 162. ITALY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. NIGERIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. NORWAY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. POLAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 179. POLAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. POLAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 181. POLAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 182. POLAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. QATAR AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 184. QATAR AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. QATAR AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 186. QATAR AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 187. QATAR AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. RUSSIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. SPAIN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 208. SWEDEN AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. TURKEY AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY VALVE TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY OPEN HEART SURGERY, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM AORTIC STENOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. AORTIC STENOSIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 234. AORTIC STENOSIS MARKET, FPNV POSITIONING MATRIX, 2023

The Aortic Stenosis Market was valued at USD 8.23 billion in 2023, expected to reach USD 8.99 billion in 2024, and is projected to grow at a CAGR of 9.63%, to USD 15.67 billion by 2030.

Aortic stenosis (AS) is a cardiovascular condition characterized by the narrowing of the aortic valve opening, restricting blood flow from the heart to the rest of the body. The market for aortic stenosis is primarily driven by the aging population, as older adults are more susceptible to this condition, thus necessitating advancements in diagnostic and treatment solutions. The application of market solutions spans several areas, including transcatheter aortic valve replacement (TAVR) and surgical procedures, with end-use settings including specialty hospitals and cardiac care centers. Key growth factors include technological advancements in medical devices, increasing awareness and diagnosis rates, and a growing pool of skilled healthcare professionals. Recent regulatory approvals and ongoing clinical trials also present significant potential opportunities, highlighting key areas such as developing minimally invasive therapies and improved patient monitoring systems. Companies can capitalize on these by investing in R&D and partnerships with healthcare providers and technology firms. However, the market faces limitations such as high costs of treatment options, stringent regulatory requirements, and limited accessibility in developing regions. Innovations are ripe in the development of next-generation valve systems that offer enhanced durability and performance, as well as digital health solutions that can assist in patient tracking and treatment optimization. Research in bioengineering for valve materials and improved imaging technologies for better diagnosis can offer substantial business growth avenues. The market is competitive, with major players focusing on mergers and acquisitions and portfolio diversification to maintain market share. Strategic collaborations for geographical expansion and tapping into emerging markets can also be effective. Continuous adaptation to evolving healthcare regulations and addressing price sensitivity can further enhance market presence and growth sustainability.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aortic Stenosis Market

The Aortic Stenosis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Government and private sector initiatives to improve healthcare infrastructure and accessibility
  • Growing investments in research and development for innovative aortic stenosis treatments and devices
  • Favorable reimbursement policies and insurance coverage for aortic stenosis treatments
  • Increasing healthcare expenditure and patient willingness to undergo surgical interventions
• Market Restraints
  • High cost of treatment
• Market Opportunities
  • Emerging minimally invasive treatments and their potential impact on the aortic stenosis market
  • The role of artificial intelligence in advancing diagnostic precision and treatment outcomes for aortic stenosis
  • Innovative patient engagement strategies to enhance care and compliance in the aortic stenosis segment
• Market Challenges
  • Stringent regulatory approvals

Porter's Five Forces: A Strategic Tool for Navigating the Aortic Stenosis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aortic Stenosis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aortic Stenosis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aortic Stenosis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aortic Stenosis Market

A detailed market share analysis in the Aortic Stenosis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aortic Stenosis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aortic Stenosis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aortic Stenosis Market

A strategic analysis of the Aortic Stenosis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aortic Stenosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Balton Sp. z o.o., Biomerics, Boston Scientific, Bracco Diagnostics, Braile Biomedica, Cardiovalve, Claret Medical, CryoLife, Edwards Lifesciences, JenaValve Technology, Johnson & Johnson, LivaNova, Medtronic, Meril Life Sciences, Micro Interventional Devices, Peijia Medical, Tarilian Laser Technologies, Terumo, and Transseptal Solutions.

Market Segmentation & Coverage

This research report categorizes the Aortic Stenosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Valve Type, market is studied across Mechanical Valves and Tissue Valves.
• Based on Surgery Type, market is studied across Minimally Invasive Surgery and Open Heart Surgery. The Minimally Invasive Surgery is further studied across Robot-Assisted Surgery and Thoracoscopic Surgery. The Open Heart Surgery is further studied across Full Sternotomy and Partial Sternotomy.
• Based on End-User, market is studied across Ambulatory Surgery Centers, Cardiac Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Government and private sector initiatives to improve healthcare infrastructure and accessibility
    • 5.1.1.2. Growing investments in research and development for innovative aortic stenosis treatments and devices
    • 5.1.1.3. Favorable reimbursement policies and insurance coverage for aortic stenosis treatments
    • 5.1.1.4. Increasing healthcare expenditure and patient willingness to undergo surgical interventions
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging minimally invasive treatments and their potential impact on the aortic stenosis market
    • 5.1.3.2. The role of artificial intelligence in advancing diagnostic precision and treatment outcomes for aortic stenosis
    • 5.1.3.3. Innovative patient engagement strategies to enhance care and compliance in the aortic stenosis segment
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory approvals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Aortic Stenosis Market, by Valve Type

• 6.1. Introduction
• 6.2. Mechanical Valves
• 6.3. Tissue Valves

7. Aortic Stenosis Market, by Surgery Type

• 7.1. Introduction
• 7.2. Minimally Invasive Surgery
  • 7.2.1. Robot-Assisted Surgery
  • 7.2.2. Thoracoscopic Surgery
• 7.3. Open Heart Surgery
  • 7.3.1. Full Sternotomy
  • 7.3.2. Partial Sternotomy

8. Aortic Stenosis Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centers
• 8.3. Cardiac Centers
• 8.4. Hospitals
• 8.5. Specialty Clinics

9. Americas Aortic Stenosis Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Aortic Stenosis Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Aortic Stenosis Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Balton Sp. z o.o.
• 3. Biomerics
• 4. Boston Scientific
• 5. Bracco Diagnostics
• 6. Braile Biomedica
• 7. Cardiovalve
• 8. Claret Medical
• 9. CryoLife
• 10. Edwards Lifesciences
• 11. JenaValve Technology
• 12. Johnson & Johnson
• 13. LivaNova
• 14. Medtronic
• 15. Meril Life Sciences
• 16. Micro Interventional Devices
• 17. Peijia Medical
• 18. Tarilian Laser Technologies
• 19. Terumo
• 20. Transseptal Solutions